KNIGHTSCOPE INC-A (KSCP)

US49907V1026 - Common Stock

20.78  +0.78 (+3.9%)

After market: 21.9 +1.12 (+5.39%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KSCP. KSCP was compared to 84 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of KSCP have multiple concerns. KSCP is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year KSCP has reported negative net income.
KSCP had a negative operating cash flow in the past year.
KSCP had negative earnings in each of the past 5 years.
In the past 5 years KSCP always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -117.06%, KSCP is not doing good in the industry: 96.43% of the companies in the same industry are doing better.
The Return On Equity of KSCP (-257.15%) is worse than 91.67% of its industry peers.
Industry RankSector Rank
ROA -117.06%
ROE -257.15%
ROIC N/A
ROA(3y)-155.08%
ROA(5y)-153.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

KSCP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

KSCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KSCP has less shares outstanding
Compared to 5 years ago, KSCP has less shares outstanding
Compared to 1 year ago, KSCP has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -10.51, we must say that KSCP is in the distress zone and has some risk of bankruptcy.
KSCP has a worse Altman-Z score (-10.51) than 96.43% of its industry peers.
KSCP has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.38, KSCP perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z -10.51
ROIC/WACCN/A
WACC8.7%

2.3 Liquidity

KSCP has a Current Ratio of 1.21. This is a normal value and indicates that KSCP is financially healthy and should not expect problems in meeting its short term obligations.
KSCP's Current ratio of 1.21 is on the low side compared to the rest of the industry. KSCP is outperformed by 71.43% of its industry peers.
KSCP has a Quick Ratio of 1.21. This is a bad value and indicates that KSCP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.84, KSCP is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.84

5

3. Growth

3.1 Past

The earnings per share for KSCP have decreased strongly by -1688.17% in the last year.
Looking at the last year, KSCP shows a quite strong growth in Revenue. The Revenue has grown by 16.66% in the last year.
KSCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.20% yearly.
EPS 1Y (TTM)-1688.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.5%
Revenue 1Y (TTM)16.66%
Revenue growth 3Y56.63%
Revenue growth 5Y34.2%
Sales Q2Q%-10.1%

3.2 Future

Based on estimates for the next years, KSCP will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.90% on average per year.
The Revenue is expected to grow by 15.70% on average over the next years. This is quite good.
EPS Next Y31.25%
EPS Next 2Y19.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.51%
Revenue Next 2Y15.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

KSCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year KSCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

KSCP's earnings are expected to grow with 19.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.9%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

KSCP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KNIGHTSCOPE INC-A

NASDAQ:KSCP (11/13/2024, 4:59:59 PM)

After market: 21.9 +1.12 (+5.39%)

20.78

+0.78 (+3.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap63.59M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -117.06%
ROE -257.15%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.21
Quick Ratio 0.84
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1688.17%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y31.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.66%
Revenue growth 3Y56.63%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y